期刊文献+

氟伐他汀对心力衰竭患者血清选择素家族的影响

Effects of fluvastatin on serum selectin family in patients with heart failure
在线阅读 下载PDF
导出
摘要 目的观察氟伐他汀短期治疗对充血性心力衰竭(CHF)患者血清中P-选择素(P-selectin)、E-选择素(E-selectin)、L-选择素(L-selectin)水平的影响,探讨氟伐他汀在CHF中的治疗作用。方法将97例CHF患者随机分为对照组和治疗组,治疗组在常规治疗的基础上加服氟伐他汀观察2周,采用酶联免疫吸附法(ELISA)测定其治疗前后血清中P-selectin、E-selectin和L-selectin水平。结果 2组治疗后血清P-selectin和E-selectin水平均较治疗前下降(P<0.05),但下降水平组间比较差异无统计学意义(P>0.05)。2组治疗后血清L-selectin水平均较治疗前无明显下降(P>0.05),治疗组甚至较治疗前有所升高(P>0.05)。结论在CHF常规治疗的基础上短期加用氟伐他汀治疗不能进一步降低血清选择素家族水平。 Objective To observe the effects of short-term treatment of fluvastatin on serum P-selectin (platelet selectin,P-selectin),E-selectin (endothelium-selectin,E-selectin) and L-selectin (leukocyte-selectin,L-selectin) in patients with congestive heart failure(CHF),and to investigate the effects of fluvastatin in the treatment of congestive heart failure. Methods 97 patients with CHF were randomly divided into control group and treatment group. The patients in treatment group,on the basis of conventional therapy,were treated with fluvastatin for 2 weeks,and enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of serum P-selectin,E-selectin and L-selectin before and after treatment.Results After treatment the serum P-selectin and E-selectin levels in both groups were decreased,as compared with those before treatment (P〈0.05),however,there was no significant difference in the decrease levels between the two groups (P〉0.05).The serum L-selectin levels in both groups were not decreased after treatment(P〈0.05),furthermore,which in treatment group were even higher than those before treatment (P〉0.05).Conclusion On the basis of routine treatment,the short-term fluvastatin treatment can not further reduce the selectin family levels.
出处 《河北医药》 CAS 2010年第21期2957-2959,共3页 Hebei Medical Journal
关键词 心力衰竭 氟伐他汀 P-选择素 E-选择素 L-选择素 heart failure fluvastatin P-selectin E-selectin L-selectin
  • 相关文献

参考文献7

  • 1Valgimigli M,Curello S,Ceconi C,et al.Neurohormones,cytokines and programmed cell death in heart failure:a new paradigm for the remodeling heart.Cardiovasc Drugs and Ther,2001,15:529-537.
  • 2Barthel SR,Gavino JD,Descheny L,et al.Targeting selectins and selectin ligands in inflammation and cancer.Expert Opin Ther Targets,2007,11:1473-1491.
  • 3吴志红,连晓芳,池云芳,孟岩,都伟,王云英,安艳荣,董学勤,任岩春.氟伐他汀对慢性心力衰竭患者血清基质金属蛋白酶的影响[J].河北医药,2009,31(5):537-538. 被引量:9
  • 4Alban S,Ludwig R,Bendas G,et al.PS3,A Semisynthetic β-1,3-Glucan Sulfate,Diminishes Contact Hypersensitivity Responses Through Inhibition of L-and P-Selectin Functions.J Invest Dermatol,2008,129:1192-1202.
  • 5Kneuer C,Ehrhardt C,Radomski MW,et al.Selectins--potential pharmacological targets.Drug Discov Today,2006,11:1034-1040.
  • 6Nawawi H,Osman NS,Annuar R,et al.Soluble intercellular adhesion molecule-1 and interleukin-6 level reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin.Atherosclerosis,2003,169:283-291.
  • 7Bleske BE,Nicklas JM,Bard RL,et al.Neutral effect on markers of heart failure,inflammation,endothelial activation and function,and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.J Am Coll Cardiol,2006,47:338-341.

二级参考文献12

  • 1杨来宝,吴润桂,李志雄,单守杰.辛伐他汀联合苯那普利干预充血性心力衰竭的作用[J].中国煤炭工业医学杂志,2005,8(10):1054-1056. 被引量:5
  • 2符明龙,卢竞前.辛伐他汀治疗扩张型心肌病[J].国外医学(心血管疾病分册),2005,32(6):367-369. 被引量:3
  • 3赵忠普,杨艳秋,方卓,刘斌.老年充血性心力衰竭患者血清基质金属蛋白酶的测定及其临床意义[J].中国老年学杂志,2006,26(9):1183-1184. 被引量:10
  • 4Egawa N, Koshikawa N, Tomari T, et al. Membrane type 1 matrix metalloproteinase( MT1-MMP/MMP-14 )cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer(EMMPRIN) fragment from tumor cells. J Biol Chem, 2006,281 : 37576-37585.
  • 5Cfisby M, Nordin-Fredriksson G, Shah PK. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque sta- bilization. Circulation, 2001, 103 : 926-933.
  • 6Lee RT, Lammerding J. Signaling pathways that influence extracenular remodeling. J Card Fail, 2002,8 : 339-343.
  • 7Horwich TB, Maclellan WR, Fonarow GC, et al. Statin therapy is associated with improved survival in ischenfic and non ischermic heart failure. J Am Coll Cardiol, 2004,43 : 642-648.
  • 8Spinale FG, Coker ML, Heung LJ, et al. A matrix naetalloproteinase induction/ activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation, 2000,102 : 1944-1949.
  • 9Li YY, Feng Y, Me Tieman CF, et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation, 2001, 104: 1147- 1152.
  • 10King MK, Coker ML, Goldberg A, et al. Selective matrix metalloproteinase inhibition with developing heart failure : effects on left ventricular function and structure. Cir Res ,2003,92 : 177-185.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部